CannaTech Cannabis House Davos 2020

DAVOS, Switzerland, 20-21 January 2020 —For the second year in a row, Stemcell United (“SCU”) participated in CannaTech Davos Cannabis House along with other thought leaders, entrepreneurs, mavericks and scientists in the global cannabis innovation field. This exclusive event highlighted the economic role of cannabis in several sectors such as healthcare, international trade and investment.

SCU was proud to be the official sponsor partner of CannaTech Davos Cannabis House, along with other partners like Canadian Securities Exchange and US-based OTC Markets.

Group CEO, Mr Philip Gu was invited to be the keynote speaker on the first day of the event. He delivered a speech titled “the Next Emerging Markets for Cannabis – Navigating Asia” where he provideda comprehensive insights on the progress in the legalization of industrial hemp and medical cannabis in Asia Pacific countries like China, Australia, Thailand, Laos, and Malaysia.

Mr Philip Gu, Davos Cannabis House 2020

Mr Philip also highlighted on the company’s application of plant stem cell technologies on industrial hemp as well as the exciting development and progress it has made in several Asia countries. He believes that with the synergy of  technological advancements of Western countries in medical cannabis and industrial hemp, Asia countries will be benefited greatly, in particular, medical and agricultural sectors.

Mr Philip Gu delivering a speech in Cannabis House Davos 2020

Multiple valuable networking sessions followed where many industry stakeholders exchanged ideas and explored collaborative opportunities.

From left to right: Mr Philip Gu, SCU Group CEO; Richard Carleton, CEO of CSE; and Michael Huang, SCU Executive Director

From left to right: Mr Philip Gu, SCU Group CEO; Jason Paltrowitz, Director of OTC Markets; and Michael Huang, SCU Executive Director